Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection

Alpha-particle radiotherapy has gained considerable attention owing to its potent anti-cancer effect. (211)At, with a relatively short half-life of 7.2 h, emits an alpha particle within a few cell diameters with high kinetic energy, which damages cancer cells with high biological effectiveness. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xuhao, Kaneda-Nakashima, Kazuko, Kadonaga, Yuichiro, Kabayama, Kazuya, Shimoyama, Atsushi, Ooe, Kazuhiro, Kato, Hiroki, Toyoshima, Atsushi, Shinohara, Atsushi, Haba, Hiromitsu, Wang, Yang, Fukase, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782038/
https://www.ncbi.nlm.nih.gov/pubmed/36559199
http://dx.doi.org/10.3390/pharmaceutics14122705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782038/
https://www.ncbi.nlm.nih.gov/pubmed/36559199
http://dx.doi.org/10.3390/pharmaceutics14122705

Ejemplares similares